Up-regulation of NEK2 by MicroRNA-128 methylation is associated with poor prognosis in colorectal cancer

Yusuke Takahashi, Takeshi Iwaya, Genta Sawada, Junji Kurashige, Tae Matsumura, Ryutaro Uchi, Hiroki Ueo, Yuki Takano, Hidetoshi Eguchi, Tomoya Sudo, Keishi Sugimachi, Hirofumi Yamamoto, Yuichiro Doki, Masaki Mori, Koshi Mimori

Research output: Contribution to journalArticlepeer-review

68 Citations (Scopus)


Background: NIMA-related kinase 2 (NEK2), an enzyme involved in the development and progression of cancer, is abnormally expressed in a wide variety of human cancers, including colorectal cancer (CRC), and is known to have roles in cell division and mitotic regulation through centrosome splitting. We investigated the clinical significance of NEK2 in CRC. In particular, we examined miR-128 expression, which is thought to target NEK2. Methods: We measured NEK2 mRNA and miR-128 levels in clinical samples by quantitative reverse transcription real-time PCR and analyzed the associations between NEK2 levels, miR-128 levels, clinicopathological factors, and prognoses. Furthermore, we performed in vitro assays using a pre-miR-128 precursor and conducted miR-128 methylation analyses. Results: MiR-128 inhibited NEK2 expression and cancer cell proliferation via cell cycle arrest. Moreover, miR-128 was silenced by DNA methylation. Increased NEK2 expression was associated with serosal invasion, lymphatic invasion, and peritoneal dissemination. Patients with high NEK2 expression also had significantly poorer prognoses. Multivariate analysis indicated that high NEK2 expression was an independent prognostic factor for survival. Patients with high miR-128 expression had significantly lower NEK2 expression and lower recurrence rates than those with low miR-128 expression. Conclusions: NEK2 may be an independent prognostic factor for CRC and was regulated by miR-128, a microRNA that was subjected to epigenetic regulation. Thus, this miR-128/NEK2 pathway may be a prospective therapeutic target for patients with CRC.

Original languageEnglish
Pages (from-to)205-212
Number of pages8
JournalAnnals of Surgical Oncology
Issue number1
Publication statusPublished - Jan 2014

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology


Dive into the research topics of 'Up-regulation of NEK2 by MicroRNA-128 methylation is associated with poor prognosis in colorectal cancer'. Together they form a unique fingerprint.

Cite this